These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28104131)

  • 21. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
    Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium.
    Shah MA; Janjigian YY; Stoller R; Shibata S; Kemeny M; Krishnamurthi S; Su YB; Ocean A; Capanu M; Mehrotra B; Ritch P; Henderson C; Kelsen DP
    J Clin Oncol; 2015 Nov; 33(33):3874-9. PubMed ID: 26438119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical efficacy of TS-1 combined with cisplatin for advanced cardiac gastric cancer with multiple liver metastases--two case reports].
    Yamada T; Watanabe A; Yamamoto K; Ishikawa H; Ohyama T; Niimi Y
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2173-7. PubMed ID: 15628766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.
    Kelsen D; Karpeh M; Schwartz G; Gerdes H; Lightdale C; Botet J; Lauers G; Klimstra D; Huang Y; Saltz L; Quan V; Brennan M
    J Clin Oncol; 1996 Jun; 14(6):1818-28. PubMed ID: 8656250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Two cases of advanced gastric cancer effectively treated with chemotherapy of 5-fluorouracil, cisplatin and cytarabine].
    Satoh T; Tsushima K; Saitoh S; Tamura Y; Hizawa Y; Itoh J; Munakata A; Yamada Y
    Gan To Kagaku Ryoho; 1997 May; 24(7):879-82. PubMed ID: 9170530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin, doxorubicin, and 5-FU in combination for advanced gastric cancer.
    Vogl SE; Engstrom PF
    Cancer Treat Rep; 1984 Oct; 68(10):1273-5. PubMed ID: 6543152
    [No Abstract]   [Full Text] [Related]  

  • 27. [Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case].
    Takahashi T; Kochi M; Kanamori N; Kaiga T; Funada T; Fujii M; Takayama T
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1885-8. PubMed ID: 19920393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of additional chemotherapy with oral UFT in intravenous combination chemotherapy with cisplatin and 5-fluorouracil for human gastric cancer xenograft lines of well- and poorly- differentiated adenocarcinomas transplanted in nude mice.
    Tseng CC; Nio Y; Tsubono M; Kawabata K; Masai Y; Hayashi H; Fukumoto M; Tobe T
    Anticancer Res; 1992; 12(4):1295-9. PubMed ID: 1503424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma.
    Bozkaya Y; Doğan M; Yazıcı O; Erdem GU; Demirci NS; Zengin N
    Bosn J Basic Med Sci; 2017 May; 17(2):138-143. PubMed ID: 28273032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of advanced gastric cancer with lung and liver metastasis treated by CDDP and 5-FU].
    Sakata Y; Okamura T; Kurimoto H; Ono K; Fuku A
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):627-30. PubMed ID: 8678523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of first-line systemic chemotherapy with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil regimens in locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma: A prospective phase II study from South India.
    Babu KG; Chaudhuri T; Lakshmaiah KC; Dasappa L; Jacob LA; Babu M; Rudresha AH; Lokesh KN; Rajeev LK
    Indian J Cancer; 2017; 54(1):47-51. PubMed ID: 29199662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).
    Bodoky G; Scheulen ME; Rivera F; Jassem J; Carrato A; Moiseyenko V; Vynnychenko I; Prausová J; Van Laethem JL; Cascinu S; Ajani JA
    J Gastrointest Cancer; 2015 Jun; 46(2):109-17. PubMed ID: 25707610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.
    Ajani JA; Moiseyenko VM; Tjulandin S; Majlis A; Constenla M; Boni C; Rodrigues A; Fodor M; Chao Y; Voznyi E; Marabotti C; Van Cutsem E;
    J Clin Oncol; 2007 Aug; 25(22):3205-9. PubMed ID: 17664467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.
    Ajani JA; Fodor MB; Tjulandin SA; Moiseyenko VM; Chao Y; Cabral Filho S; Majlis A; Assadourian S; Van Cutsem E
    J Clin Oncol; 2005 Aug; 23(24):5660-7. PubMed ID: 16110025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A long-term survivor of metastatic gastric cancer treated by chemotherapy: case report.
    Nagase K; Ohtsu A; Saito Y; Saito M; Ikeya S; Ishii N; Nakayama H; Hoshino E; Sugai Y; Wachi E
    Jpn J Clin Oncol; 1991 Aug; 21(4):299-305. PubMed ID: 1942559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A successful resected case of advanced esophageal cancer with early gastric cancer responding to neoadjuvant chemotherapy of docetaxel, CDDP and 5-FU].
    Matsutani T; Yoshida H; Sasajima K; Maruyama H; Yokoyama T; Matsushita A; Hirakata A; Takao Y; Umakoshi M; Hayakawa T; Katayama H; Hosone M; Uchida E
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):645-8. PubMed ID: 22504694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of docetaxel, cisplatin, and 5-fluorouracil in advanced gastric cancer: a single-institution experience.
    Ben Aharon I; Purim O; Kundel Y; Brenner R; Gordon N; Sulkes A; Brenner B
    Anticancer Drugs; 2012 Mar; 23(3):313-20. PubMed ID: 22241172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of gastric cancer with multiple liver metastasis responding to combined chemotherapy with low-dose cisplatin and 5-fluorouracil].
    Shinkawa H; Wada N; Naka S; Yasuhara H; Kuroda T; Nojiri T; Inoue T; Fujita T; Furuya Y; Okazaki K; Nagao T; Nagao K
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):909-13. PubMed ID: 10897220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.
    Lordick F; Kang YK; Chung HC; Salman P; Oh SC; Bodoky G; Kurteva G; Volovat C; Moiseyenko VM; Gorbunova V; Park JO; Sawaki A; Celik I; Götte H; Melezínková H; Moehler M;
    Lancet Oncol; 2013 May; 14(6):490-9. PubMed ID: 23594786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histological complete response after neoadjuvant XELOX in advanced gastric carcinoma.
    Zhao Q; Li Y; Tian Y; Chen YN; Tan BB; Zhao XF; Jiao ZK; Zhang ZD; Chang SL
    Hepatogastroenterology; 2013 May; 60(123):638-40. PubMed ID: 23340232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.